arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

HCW Biologics Inc.

HCWB

$3.48 ▲ +0.08 (+2.50%) at close

26 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

HCW Biologics Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $18.9M

Dividend Yield —

Revenue Growth 128231.7%

Op. Margin 49.8%

ROIC 51.3% ↗

FCF / Share $-0.29

Trailing P/E 9.4x

Price / Book 3.3x

FCF Yield —

Debt / Equity 1.14

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$6.50M

↑ +128231.7% —

Net Income Profit after all expenses

$3.47M

↑ +382.8% —

Operating Margin Operating profit as % of sales

49.8%

↑ +122.4% —

FCF / Share Free cash flow per share

$-0.29

↓ -269.1% —

Long-Term Debt Long-term obligations

$0.00

— —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	128231.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1602796%)	—	-96.3% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1304%)	-98.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1337%)	-99.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1344%)	—	-50.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-725%)	-0.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-108%)	2590.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+32277%)	—	-52.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-761%)	37.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+365%)	-98.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1333%)	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	N/M	-1920.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-1597.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	75.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-776.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	28.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-233.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-42.9% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	-87.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-27.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-20.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	N/M	21.4% Good Good Year-over-year change in earnings per share Optimal: > 10%	84.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	70.6% Excellent → Excellent Stable Year-over-year change in net income	70.6% Excellent ↑ Excellent Improving Year-over-year change in net income	70.6% Excellent ↑ Excellent Improving Year-over-year change in net income	68.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-47.3% Weak ↑ Weak Improving Year-over-year change in net income	-47.3% Weak ↑ Weak Improving Year-over-year change in net income	-47.3% Weak ↑ Weak Improving Year-over-year change in net income	-97.1% Weak ↑ Weak Improving Year-over-year change in net income	-146.5% Weak ↓ Weak Declining Year-over-year change in net income	-146.5% Weak ↓ Weak Declining Year-over-year change in net income	-146.5% Weak ↓ Weak Declining Year-over-year change in net income	-70.8% Weak ↓ Weak Declining Year-over-year change in net income	27.7% Excellent → Excellent Stable Year-over-year change in net income	27.7% Excellent ↑ Excellent Improving Year-over-year change in net income	27.7% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-19.7% Weak Weak Year-over-year change in net income	-19.7% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	-269.1% Weak Weak Year-over-year change in free cash flow	—	—	—	21.6% Good Good Year-over-year change in free cash flow	—	—	—	8.6% Fair ↑ Fair Improving Year-over-year change in free cash flow	—	50.3% Excellent Excellent Year-over-year change in free cash flow	-304.0% Weak Weak Year-over-year change in free cash flow	—	—	-101.1% Weak Weak Year-over-year change in free cash flow	62.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	437.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	—	-79.5% Weak → Weak Stable Compound annual revenue growth over 3 years	-75.7% Weak Weak Compound annual revenue growth over 3 years	-88.2% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	49.8% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+232%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-222.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1581%)	—	-60.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-502%)	—	—	—	—	50.3% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+235%)	—	—	—	—
Effective Tax Rate (%) (%)	8.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	53.4% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+345%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-113.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1048%)	-453.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3876%)	-66.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-650%)	—	—	—	—	50.3% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+319%)	—	—	—	—
FCF Margin (%) (%)	-24.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	-331.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	-51.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	-87.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	-0.45x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-4.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.47x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.49x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.60x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.23x Good → Good Stable Free cash flow relative to reported net income Optimal: > 1x	2.16x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	6.07x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.31x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.80x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.73x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.20x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	51.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-127.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	123.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-868.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	181.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-409.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	83.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-332.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-43.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	9.4% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	13.5% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	11.7% Good Good Return earned on debt + equity capital invested Optimal: > 10%	14.3% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	11.8% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	-18.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-56.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-37.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-12.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-12.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-3.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-5.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	13.4% Good Good Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	60.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+302%)	26.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+73%)	104.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+595%)	—	25.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+71%)	49.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+232%)	74.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+399%)	118.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+690%)	-85.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-670%)	-79.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-629%)	-21.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-17.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-218%)	-15.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	-14.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-197%)	-4.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-4.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-4.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-128%)	-6.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-5.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	12.2% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	14.2% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-5%)	-12.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	12.9% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-14%)	15.4% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	1.14x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+90%)	2.46x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+310%)	-3.23x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-638%)	-130.62x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-21869%)	-1.63x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-371%)	-2.02x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-437%)	-1.28x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-314%)	-1.57x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-362%)	0.95x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+58%)	0.47x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-22%)	—	—	0.20x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-67%)	0.17x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	—	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—
Interest Coverage (x)	29.61x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-21.03x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-25.91x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.15x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.68x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.09x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-16.52x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-94.80x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-7567.25x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-53.16x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-47.22x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-57.37x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-59.99x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-124.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-10.66x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-1611.09x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-7242.33x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$5.35M	$4.86M	$5.71M	$4.35M	$12.83M	$9.02M	$11.81M	$8.74M	$4.19M	$2.71M	—	—	$-12.00M	$-15.92M	—	—	$-18.12M	$-11.73M	—	—	—	$-8.46M	$-6.48M	$-3.17M	—	$-7.36M
Debt / EBITDA (x)	1.95x Good ↑ Good Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.53x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.07x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.96x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-9.01x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-4.35x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.59x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.66x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.14x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.60x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-1.26x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.19x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$1.20	—	$0.01	$0.00	$0.00	—	$0.01	$0.02	$0.03	—	$0.02	$0.02	$0.00	—	$0.05	$0.01	—	—	$0.00	$0.00	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.37	$0.71	$-2.02	$-6.79	$-0.05	$-2.63	$-0.10	$-0.40	$-0.20	$-0.30	$-0.14	$-0.12	$-0.14	$-0.16	$-0.11	$-0.10	—	$0.05	$-0.14	$-0.66	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.29	—	$-1.43	$-1.84	$-0.08	—	—	—	$-0.10	—	$-0.17	$-0.30	$-0.11	—	$-0.35	$-0.08	—	—	$-0.17	$-0.20	—	—	—	—	—	—
Book Value per Share (USD)	$1.06	—	$-0.93	$-0.03	$-0.19	—	$-0.26	$-0.17	$0.23	—	$0.66	$0.80	$0.91	—	$1.19	$1.29	—	—	$1.83	$-4.72	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$1.06	—	$-0.93	$-0.03	$-0.19	—	$-0.26	$-0.17	$0.23	—	$0.66	$0.80	$0.91	—	$1.19	$1.29	—	—	$1.83	$-4.72	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	5.43M	—	2.26M	1.78M	44.68M	—	37.82M	37.82M	37.22M	—	35.93M	35.91M	35.88M	—	35.84M	35.81M	—	—	29.57M	4.92M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$-18.24M	$-18.78M	$-25.27M	$-23.95M	$-25.25M	$-23.93M	$-27.97M	$-20.83M	$-7.20M	$-2.34M	—	—	$25.42M	$31.11M	—	—	$36.49M	$38.16M	—	—	—	$11.15M	—	—	—	—
LT Debt (USD)	—	$0.00	$0.00	$367.15K	$7.71M	$7.38M	$6.46M	$9.90M	$8.27M	$6.30M	—	—	$6.39M	$6.41M	—	—	—	$0.00	—	—	—	—	—	—	—	—
Total Equity (USD)	$5.76M	$2.76M	$-2.11M	$-51.97K	$-8.56M	$-6.77M	$-9.97M	$-6.30M	$8.74M	$13.46M	$23.87M	$28.59M	$32.62M	$37.43M	$42.56M	$46.17M	$49.40M	$51.19M	$54.01M	$-23.24M	$-20.03M	$-16.72M	$-18.37M	$-15.38M	$-12.33M	$-9.68M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Dec 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$6.50M	—	$15.61K	$6.55K	$5.07K	—	$426.42K	$618.85K	$1.13M	—	$853.10K	$622.81K	$41.88K	—	$1.81M	$454.00K	$3.12M	—	$0.00	$0.00	$0.00	$4.10M	$0.00	$0.00	—	—
Depreciation Expense (USD)	$142.05K	—	—	—	$419.01K	—	$128.45K	$129.93K	$243.50K	$274.55K	$277.45K	$284.33K	$298.85K	$261.16K	$164.33K	$149.58K	$142.78K	$107.46K	$122.46K	$154.87K	$158.81K	$140.64K	$126.21K	—	—	—
Net Income, GAAP (USD)	$3.47M	$719.23K	$-2.20M	$-2.20M	$-2.20M	$-3.37M	$-7.47M	$-7.47M	$-7.47M	$-10.68M	$-5.07M	$-5.07M	$-5.07M	$-5.42M	$-2.06M	$-2.06M	$-2.06M	$-3.17M	$-2.84M	$-2.84M	$-2.84M	$2.06M	$-2.38M	$-2.38M	—	—
Operating Cash Flow (USD)	$-1.58M	$-3.36M	$-3.24M	$-3.28M	$-3.51M	$-2.83M	—	—	$-3.60M	$-3.89M	$-5.59M	$-9.39M	$-3.64M	$-3.79M	$-2.31M	$-2.69M	$-1.59M	$-3.38M	$-5.12M	$-990.44K	$-1.49M	$-3.54M	$-2.75M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

HCW Biologics Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HCWB with peers